Cancer: looking for simplicity and finding complexity by Grizzi, Fabio & Chiriva-Internati, Maurizio
BioMed  Central
C
TIONAL INTERNA
CANCER CELL
Page 1 of 7
(page number not for citation purposes)
Cancer Cell International
Open Access Review
Cancer: looking for simplicity and finding complexity
Fabio Grizzi*1,2 and Maurizio Chiriva-Internati3
Address: 1Laboratori di Medicina Quantitativa, Istituto Clinico Humanitas IRCCS, 20089 Rozzano, Milan, Italy, 2"Michele Rodriguez" 
Foundation, Scientific Institute for the Quantitative Measures in Medicine, 20054 Milan, Italy and 3Department of Microbiology & Immunology, 
Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas 79430, USA
Email: Fabio Grizzi* - fabio.grizzi@humanitas.it; Maurizio Chiriva-Internati - maurizio.chiriva@ttuhsc.edu
* Corresponding author    
Abstract
Cancer is one of the most complex dynamic human disease. Despite rapid advances in the fields of
molecular and cell biology, it is still widely debated as to how neoplastic cells progress through
carcinogenesis and acquire their metastatic ability. The need to find a new way of observing
anatomical entities and their underlying processes, and measuring the changes they undergo,
prompted us to investigate the Theory of Complexity, and to apply its principles to human cancer.
Viewing a neoplasm as a system that is complex in time and space it is likely to reveal more about
its behavioral characteristics, and this manner of thinking may help to clarify concepts, interpret
experimental data, indicate specific experiments and categorize the rich body of knowledge on the
basis of the similarities and/or shared behaviors of very different tumors.
Introduction
Carcinogenesis has long been thought to be a multi-step
process [1]; however, it has only recently become possible
to identify a large number of the molecular events under-
lying the initiation  and  progression  of different human
tumors [2]. After a quarter century of rapid advances, can-
cer research has generated an intricate body of knowledge
showing that cancer is a disease that involves dynamic
changes in the genome [3].
The foundations of this knowledge were mainly laid by
the discovery of genomic alterations or mutations that pro-
duce  oncogenes  with a dominant gain of function and
tumour-suppressor genes with a recessive loss of function.
Both of these cancer gene classes were identified on the
basis of their alterations in human and animal neoplastic
cells, and their elicitation of cancer phenotypes in experi-
mental models [4-7].
Although considerable advances have been made in terms
of our molecular and cellular knowledge, very little is
understood about the physics underlying human carcino-
genesis. It is now well known that the conception of ana-
tomical entities as an infinite hierarchy of infinitely
graduated forms and the increasing discoveries of func-
tional variables have generated a growing awareness of
complexity, thus highlighting new and exciting properties
of organized biological matter [8].
More than 100 distinct types of human cancer have been
described, and subtypes of tumors can be found within
specific organs. Cancer is increasingly recognized as being
a highly heterogeneous disease within individual tumors,
and within and between tumour types [9]. This heteroge-
neity is manifested at both genetic and phenotypic level,
and primarily determines the self-progression of neoplastic
disease and its response to therapy.
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The discovery of this increasing complexity has led many
researchers to ask a number of stimulating questions.
How many distinct regulatory circuits within each type of
target cell must be disrupted in order to make it become
cancerous? Does the same set of cell regulatory circuits
suffer disruption in the cells of the disparate neoplasms
arising in humans? And, if we had a complete description
of all of the molecular reactions occurring within a living
normal cell and its tumoral counterpart, would we under-
stand that cell?
Scientists seldom give much thought to such questions,
and so it was an unusual gathering that assembled in 1997
in order to discuss how far a reductionist approach can take
biology [10]. Reductionism seeks to explain the wide vari-
ety of natural phenomena on the basis of the behavior of
a limited number of simpler constituents subject to rigor-
ous and simple laws [8]. It has been a powerful driving
force in science, and its success is plainly evident in the
impressive triumphs of molecular biology that have
allowed us to understand the molecular basis of such dif-
ferent areas as developmental and cell biology, immunol-
ogy, and general and systemic human pathology [10,11].
However, the question remains as to how to transform
this molecular knowledge into an understanding of the
complex phenomena existing in genes, sub-cellular entities,
cells,  tissues,  organs,  apparatuses  and  organism  (Figure 1)
[12-22].
The need to tackle system complexity has become even more
apparent since the completion of the various genome
projects, an approach that has stimulated a search for new
ways of developing our quantitative understanding of the
complex processes underlying cancer initiation, progres-
sion and metastasis. The pioneering words of Sydney
Brenner ("In the next 25 years, we are going to have to
teach biologists another language....I don't know what its
called yet; nobody knows....") can today be considered a
manifestation of "modernity" [23,24].
A quantitative system-level understanding of cancer biol-
ogy basically requires a mathematical framework that is
Human beings are complex hierarchical systems consisting of a number of hierarchical levels of anatomical organization (genes,  sub-cellular entities, cells, tissues, organs, apparatuses, and organism) that interrelate differently with each other to form net- works of growing complexity Figure 1
Human beings are complex hierarchical systems consisting of a number of hierarchical levels of anatomical organization (genes, 
sub-cellular entities, cells, tissues, organs, apparatuses, and organism) that interrelate differently with each other to form net-
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capable of describing the principles governing the struc-
ture and behavior of a tumour [25,26]. Moreover modeling
the growth and development of human tumors using
mathematics and biological data has become a burgeon-
ing area of cancer research [27-34]. Mathematical models
represent a compulsory tool for organizing the large
amounts of data concerning the genetic and biochemical
pathways of cancer, and providing an advanced interpre-
tation of its dynamics and control.
We here discuss cancer as a complex dynamic disease, and
introduce some of the critical concepts necessary to give
meaning of its underlying physical complexity.
Multi-state carcinogenesis: a) the schema shows the progression of different qualitative states (x1, x2....xn-1, xn) identifiable in the  development of cancer from normal tissue Figure 2
Multi-state carcinogenesis: a) the schema shows the progression of different qualitative states (x1, x2....xn-1, xn) identifiable in the 
development of cancer from normal tissue. The time parameter (t0, t1... ....tn-1, tn) depends on a large number of variables inter-
connected in many ways in a non-linear manner. This makes it extremely difficult to predict the exact time interval between 
two successive states. Although carcinogenesis is a continuum, its differentiation into successive states is still based on differ-
ences in histological and clinical data. Examples of dynamical view of colorectal (b) pancreatic (c) and liver (d) carcinogenesis 
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Cancer is a dynamic system
Carcinogenesis is one of the most complex phenomena in
biology. Cancer is a dynamic system that is discontinuous
in space and time, but advances through qualitatively dif-
ferent states: i.e. the configuration of a system at any par-
ticular instant that is specified by a great number of
dynamic variables [35].
In mathematical terms, a dynamic system depends on a
set of different states or possible configuration patterns (x),
and a number of transitions or steps ( ) from one state to
another during a certain interval of time (t). When the
transitions are caused by a generating factor (u), the tem-
poral behavior of the system can be theoretically
described using general equation 1:
 = f(x, u, t)   1)
where f is a continuous non-linear function and the dot
denotes a differentiation with respect to time (t) [35-37].
The parameter time depends on a large number of varia-
bles that are non-linearly interconnected in a multitude of
ways, thus making it extremely difficult to predict the
exact time interval between two successive states (Figure
2).
These states may or may not proceed to a more advanced
state [35].
The continuous generation of unstable states during the
course of carcinogenesis (initiation → progression →
metastasis) has led to every sort of reorganization of dif-
ferent entities due to a change in the parameters on which
they depend being physically defined as a bifurcation,
whereas the term catastrophe describes an abrupt change
that occurs as a sudden reaction of the system to a regular
variation in external conditions [35-37]. In clinical terms,
bifurcation could be used to describe a genomic mutation
in a cell that drastically changes its behavior from normal
to malignant, or a transformation from an in situ lesion to
invasive cancer.
The genetic model for colorectal tumorigenesis originally
proposed by Fearon and Vogelstein in 1990 was a pio-
neering view of cancer as a dynamic system [38]. Colorec-
tal tumorigenesis proceeds through a series of genetic
alterations that mainly involve oncogenes and tumour-
suppressor genes. An additional defining feature of color-
ectal cancer is its genetic instability [29,39]. Two main types
of genetic instability have been now identified: a) micros-
atellite instability leads to an increased point mutation rate,
and b) chromosomal instability which refers to an enhanced
rate of accumulating gross chromosomal aberrations
[29,39].
Although the alterations usually occur at a characteristic
state of tumour advancement, experimental evidence
indicates that the ongoing accumulation of changes rather
than their order of occurrence is more important in the
course of cancer [38].
In physical terms, it is true that alterations in one param-
eter (i.e. chromosomal changes, DNA changes, specific
gene changes or mitochondrial changes) are not necessar-
ily associated with the loss of stability of a system, and it
is also true that an unstable system is more sensitive to
small changes in parameters (i.e. its state is more easily
modifiable): in biological words, a growing network of
cancer-susceptibility genes is formed as the neoplasm
advances [35-41].
The human genome is typically so stable that the many
genetic alterations required for cancer to develop cannot
accumulate unless the rate of mutation increases to the
point of making it genetically unstable [35,41].
Stelling et al. have used the term robustness to describe the
ability of living systems to maintain performance (pheno-
typic stability) in the face of perturbations arising from
environmental changes, stochastic events (or intracellular
noise) and genetic variations [42], and cancer has been
shown to be an extremely heterogeneous disease with a
high level of robustness against a range of therapeutic
effects [43-45].
Cancer is a hierarchical system
The decisive step in carcinogenesis is the result of an irre-
versible qualitative change in one or more of the genetic
characteristics of cancer cells. Although this modification
governs the transformation of normal human cells into
malignant cancer cells, it may or may not lead to visible
changes in their cytological or histological structures [35].
This can be explained using the concept of emergence,
which defines a human being as a complex system con-
sisting of different anatomical entities that are intercon-
nected at many organizational levels (a hierarchical
system), have various degrees of complexity, and are gov-
erned by specific laws that only operate at a particular
level (Figure 1).
Emergence is a seminal concept in system theory, where it
denotes the principle that the "emergent" global proper-
ties defining higher order systems or "wholes" cannot gen-
erally be reduced to the properties of the lower order
subsystems or "parts". We shall here use the word emergence
to mean the appearance of unexpected structures and/or the
occurrence of surprising behaviors in large systems consist-
ing of microscopic (physical or biological) non-identical
parts: i.e. structures and behaviors that are not intuitive or
simply predictable [46-48].
 x
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In the experimental sciences, observed processes and pat-
terns can often be conceptualized as macro-scale manifes-
tations of micro-scale processes. However, in many cases, a
more typical situation involves observed patterns or sys-
tem states that are created or influenced by multiple proc-
esses and controls [49].
Cancer is determined by a number of processes and con-
trols operating over much broader scales, and by factors
such as structural controls that may operate at scales rang-
ing from molecular to environmental (Figure 3).
This multiple scale causality not only recognizes multiple
processes and controls acting at multiple scales but, unlike
a strict reductionist approach, may also recognize the fact
that relevant "first principles" may reside at scales other
than the smallest micro-scales. In other words, the
observed phenomenon at each scale has structural and
behavioral properties that do not exist at lower or higher
organizational levels.
The results of several lines of research indicate that neo-
plastic cells share a common set of biological attributes
(or "acquired capabilities") that operate and are control-
led at different spatial and temporal scales, including their
abilities:
a) to generate their own mitogenic signals;
b) to resist exogenous growth-inhibitory signals;
c) to evade apoptosis, and senescence;
d) to proliferate without limit;
e) to acquire vasculature (i.e. to undergo angiogenesis);
f) to invade and metastasize distant sites, i.e. organs (in
more advanced cancers).
Aside from these shared behavioral characteristics and
environmental conditions, it is necessary to emphasize
that each cancer cell is a self-governing entity, which has the
capability to progress independently by other surround-
ing cells.
Cancer: looking for simplicity and finding 
complexity
Despite the rapid advances that have been made in the
fields of molecular and cellular biology, there is no doubt
that cancer is still now a very complex disease: it can be
hypothesized that each tumour is unique, and that the
spectrum of biological changes determining human
tumors is infinitely variable.
As described above, carcinogenesis is a dynamic process
that depends on a large number of variables and is regu-
lated at multiple spatial and temporal scales, thus making
it one of the most complex phenomena in biology. Car-
cinogenesis is a non-linear process, whose behaviour does
not follow clearly predictable and repeatable pathways.
In linear systems, the relationship between an environmen-
tal factor increases, the system behaviour changes linearly
Hierarchical manifestation of human cancer Figure 3
Hierarchical manifestation of human cancer. Neoplasia is a 
complex system determined by a number of processes acting 
at different molecular and cellular scales, by controls operat-
ing over much broader scales, and by factors such as struc-
tural controls that may operate at scales ranging from 
molecular to environmental. The schema exemplify some of 
the manifestations that can be found at different level of can-
cer complexity, all of them acting and governed by specific 
laws that only operate at a particular level.
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in response to it. In contrast, behaviour of chaotic systems
i.e. systems that exhibit variability, which may not be nec-
essarily random, yet whose complex patterns are not dis-
cernible over a normal human time and spatial scale, may
be perceived as unpredictable.
Periods of inactivity may be punctuated by sudden
change, apparent patterns of behaviour may disappear
and new patterns surprisingly emerge. Such behaviour
emerges in complex systems, and are permanently sensi-
tive to small perturbations. This chaotic behaviour does
not indicate a lack of order. Rather, the order is difficult or
impossible to describe in simple terms and requires com-
plex narrative description.
However, non-linear systems are mainly characterised by
three basic properties: (a) they do not react proportionally
to the magnitude of their inputs; (b) they depend on their
initial conditions. Small changes in the initial conditions
may generate very different end points. (c) their behaviour
is not deterministic.
According to non-linear mathematics, the carcinogenetic
process can be defined as a system of evolving anatomical
structures, each consisting of a virtually infinite number of
interconnected parts and being governed by a large
number of biological sub-processes that are different in
time and space. In such a system: (a) the relationships
between the parts are non-linear; (b) the variables influ-
encing the behaviour of the system are interconnected in
a complex manner; (c) the individual component parts
show systematic heterogeneity; (d) small alterations in
variables can lead to completely different outcomes; (e)
the classical notions of cause and effect are replaced by
concepts involving control, bifurcation, energy and turbu-
lence.
The above characteristics are frequently shown by the fact
that it is common to see differences in the progression or
therapeutic response of the same tumour type, and the
fact that cancer morphology does not always reveal an
underlying biology.
Cancer does not conform to simple mathematical princi-
ples: the irregular mode of carcinogenesis, erratic tumour
growth, variable response to tumoricidal agents, and
poorly understood metastatic patterns constitute highly
variable clinical behaviors.
In conclusion, the above reflections have led us to think
that:
a) Cancer is a highly complex disease in time and in space.
b) In order to understand a problem that involves so many
interacting systems within the same organism, we need to
determine the type of data that needs to be collected at
each level of organization, the boundary conditions to use
when describing the disease (i.e. a perturbed system), and
the technologies and approaches best suited to reveal its
etiology.
c) Considering cancer as a robust system would provide us
with a framework for future research strategies, and future
cancer therapies may be judged on their ability to help
control the robustness of tumors.
d) Modelling the growth and development of human
tumours using mathematics and biological data is a bur-
geoning area of cancer research. Mathematical methods
and their derivatives have proved to be possible and prac-
tical in oncology [31], but the current models are often
simplifications that ignore vast amounts of knowledge:
for example, most metabolic models seem to regard a cell
as a bag of enzymes, and neglect its spatial heterogeneity
and compartmentalisation [18]; furthermore, most mod-
els struggle to resolve the 10–12 order-of-magnitude span
of the timescales of systemic events, be they molecular
(ion channel gating: 10-6 sec), cellular (mitosis: 102–103 sec)
or physiological (cancer progression: 108 sec) [8].
Viewing cancer as a system that is dynamically complex in
time and space will probably reveal more about its under-
lying behavioural characteristics. This way of thinking
may further help to clarify concepts, interpret new and old
experimental data, indicate alternative experiments and
categorise the acquired knowledge on the basis of the
similitude and/or shared behaviours of very different
tumours. It is encouraging that mathematics, theoretics,
biology and medicine continue to contribute together
towards a common quantitative understanding of cancer
complexity.
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